|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D24.2 |
Benign neoplasm of left breast
|
D242 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 50.58%
|
24.62%
|
11.50%
|
5.99%
|
2.89%
|
1.48%
|
0.89%
|
0.62%
|
0.36%
|
0.31%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D24.2*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
5,775
|
7,075
|
|
77065
|
DX MAMMO INCL CAD UNI |
3,829
|
3,832
|
|
A4648
|
IMPLANTABLE TISSUE MARKER |
3,380
|
3,868
|
|
19081
|
BX BREAST 1ST LESION STRTCTC |
2,304
|
2,305
|
|
J3010
|
FENTANYL CITRATE INJECTION |
2,276
|
3,442
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
2,272
|
67,254
|
|
19083
|
BX BREAST 1ST LESION US IMAG |
2,250
|
2,251
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
2,220
|
2,635
|
|
J2405
|
ONDANSETRON HCL INJECTION |
2,050
|
8,781
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
1,723
|
8,290
|
|
76098
|
X-RAY EXAM SURGICAL SPECIMEN |
1,712
|
1,795
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
1,696
|
1,696
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
1,598
|
1,848
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
1,588
|
10,851
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,446
|
1,452
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
1,387
|
2,856
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
1,342
|
2,839
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
1,298
|
5,745
|
|
19125
|
EXCISION BREAST LESION |
1,276
|
1,276
|
|
76642
|
ULTRASOUND BREAST LIMITED |
1,103
|
1,110
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D24.2 related to the following DRG Codes:
606-607
|
